feed,title,long_url,short_url
Benzinga,Allena Revises Interim Reloxaliase Analysis Targeted Now For Q1 2022; ALLN-346 Phase 2 Data On Track For End Of 2021,https://benzinga.com/general/biotech/21/07/21938122/allena-revises-interim-reloxaliase-analysis-targeted-now-for-q1-2022-alln-346-phase-2-data-on-tra,https://j.mp/3xN3kDa
